Hite Christopher sold RPRX

September 22, 2026 · Form 4 insider transaction

Hite Christopher sold 3,927 shares of Royalty Pharma plc at $58.93 per share, a transaction worth $231.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
3,927
Price
$58.93
Total value
$231.4K
Role—
SecurityClass A Ordinary Shares
Transaction codeS: Open-market sale
Transaction dateSeptember 22, 2026
Filing dateSeptember 24, 2026
Shares owned after270,401
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on March 20, 2026.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.88 to $59.00 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

View the original Form 4 on SEC EDGAR
Hite Christopher sold RPRX: September 22, 2026 | Insider Trading Screener